<DOC>
	<DOCNO>NCT00130871</DOCNO>
	<brief_summary>The study evaluate efficacy intravenous levosimendan treatment start coronary artery bypass operation wean patient heart lung machine .</brief_summary>
	<brief_title>Levosimendan Pretreatment Weaning Patients From Cardio-Pulmonary Bypass</brief_title>
	<detailed_description>Levosimendan placebo infusion start time induction anesthesia .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Three vessel coronary artery disease . Indication onpump coronary artery bypass surgery . Ejection fraction 50 % Indication cardiac valve surgery Previous coronary artery bypass surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>wean</keyword>
	<keyword>cardio-pulmonary bypass</keyword>
</DOC>